ENTITY

AptaBio Therapeutics (293780 KS)

Analysis

Health Care • South Korea

Aptabio Therapeutics Inc. operates pharmaceutical production businesses. The Company produces anticancer drugs and other pharmaceutical products. Aptabio Therapeutics conducts businesses in Korea.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00